Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Shares of Icosavax, Inc. (NASDAQ:ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Icosavax also reported topline interim Phase 2 results for combination VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults.

Icosavax shares gained 44.8% to $15.19 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Bruush Oral Care Inc. (NASDAQ:BRSH) shares rose 76.8% to $0.2882 in pre-market trading after gaining over 5% on Monday.
• Connect Biopharma Holdings Limited (NASDAQ:CNTB) rose 32.2% to $1.19 in pre-market trading. Connect Biopharma will present top-line data from the global Phase 2b trial evaluating rademikibart’s efficacy and safety in patients with moderate-to-severe asthma on Dec. 12, 2023.
• Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares rose 28% to $0.3159 in pre-market trading. Kaival Brands recently appointed James W. Dobbins as General Counsel.
• IN8bio, Inc.(NASDAQ:INAB) gained 25.8% to $1.61 in pre-market trading after the company announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.
• Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 21.2% to $0.1649 in pre-market trading after falling 11% on Monday.
• Hanryu Holdings, Inc. (NASDAQ:HRYU) shares surged 16% to $0.73 in pre-market trading after jumping 40% on Monday.
• TeraWulf Inc. (NASDAQ:WULF) shares gained 12% to $1.59 in pre-market trading after falling 22% on Monday.
• Tenax Therapeutics, Inc. (NASDAQ:TENX) shares climbed 10.6% to $0.2999 in pre-market trading.
• Blue Bird Corporation (NASDAQ:BLBD) shares rose 7.3% to $23.40 in pre-market trading after the company reported better-than-expected financial results for its fourth quarter and increased its FY24 revenue forecast.

Losers

• Harbor Custom Development, Inc. (NASDAQ:HCDI) shares fell 18.6% to $0.5538 in pre-market trading. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.
• SRIVARU Holding Limited (NASDAQ:SVMH) fell 17.3% to $0.5958 in pre-market trading after jumping 20% on Monday.
• Achieve Life Sciences, Inc. (NASDAQ:ACHV) shares fell 21.1% to $4.30 in pre-market trading. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline.
• Assure Holdings Corp. (NASDAQ:IONM) shares fell 13.4% to $0.3740 in pre-market trading after climbing over 23% on Monday.
• Clearmind Medicine Inc. (NASDAQ:CMND) fell 13.2% to $2.64 in pre-market trading. Clearmind Medicine filed for mixed shelf of up to $50 million.
• Exicure, Inc. (NASDAQ:XCUR) shares fell 12.2% to $0.5480 in pre-market trading after jumping over 20% on Monday.
• Assembly Biosciences, Inc. (NASDAQ:ASMB) fell 11.1% to $0.6750 in pre-market.
• Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares fell 11% to $0.7034 in pre-market trading after gaining 23% on Monday.
• Hempacco Co., Inc. (NASDAQ:HPCO) shares fell 10.8% to $0.3606 in pre-market trading.
• Oracle Corporation (NYSE:ORCL) fell 8.5% to $105.40 in pre-market trading. Oracle reported upbeat earnings for its second quarter, while sales missed estimates.

Now Read This: Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday